Avelumab in chemotherapy-refractory metastatic Merkel cell carcinoma: Subgroup analysis of efficacy.

被引：0
|
作者：
Kaufman, Howard L.
Russell, Jeffrey
Hamid, Omid
Bhatia, Shailender
Terheyden, Patrick
D'Angelo, Sandra P.
Shih, Kent C.
Lebbe, Celeste
Linette, Gerald P.
Milella, Michele
Brownell, Isaac
Lewis, Karl D.
Lorch, Jochen H.
von Heydebreck, Anja
Mahnke, Lisa
Nghiem, Paul
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Angeles Clin & Res Inst, Los Angeles, CA USA
[4] Univ Washington, Med Ctr, South Lake Union, Seattle, WA 98195 USA
[5] Univ Lubeck, Lubeck, Germany
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[7] Sarah Cannon Res Inst, Tennessee Oncol, Nashville, TN USA
[8] CHU Paris, GH St Louis Lariboisiere F Widal, Hosp St Louis, Paris, France
[9] Univ Washington, Sch Med, Seattle, WA 98195 USA
[10] Ist Nazl Tumori Regina Elena IRCCS, Rome, Italy
[11] Natl Canc Inst, Bethesda, MD USA
[12] Univ Colorado Denver, Sch Med, Aurora, CO USA
[13] Dana Farber Canc Inst, Boston, MA 02115 USA
[14] Merck KGaA, Darmstadt, Germany
[15] EMD Serono, Billerica, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.80
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
80
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma
    Gaiser, Maria Rita
    Bongiorno, Michelle
    Brownell, Isaac
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 345 - 359
  • [32] Prognosis for patients with metastatic Merkel cell carcinoma with a complete response on avelumab treatment
    Zijlker, L.
    Levy, S.
    Wolters, W.
    van Thienen, H. V.
    van Akkooi, A. C. J.
    Tesselaar, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S687 - S688
  • [33] Avelumab in Patients with metastatic Merkel Cell Carcinoma - A Question of the Length of the Therapy Interval?
    Boettjer, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 88 - 88
  • [34] Rapid Response of a multilocular metastatic Merkel Cell Carcinoma with an unclear Primarius to Avelumab
    Bender-Saebelkampf, S.
    Berking, C.
    Erdmann, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 46 - 46
  • [35] Metastatic Merkel Cell Carcinoma in Patients with CLL - Therapeutic Success with Avelumab and Chlorambucil
    Duecker, P.
    Huening, S.
    Lorenzen, J.
    Nashan, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 90 - 90
  • [36] Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?
    Glutsch, V.
    Kneitz, H.
    Goebeler, M.
    Gesierich, A.
    Schilling, B.
    ANNALS OF ONCOLOGY, 2019, 30 (10) : 1667 - 1668
  • [37] Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
    Min, Sandy Tun
    Nordman, Ina I. C.
    Tran, Huy A.
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 639 - 643
  • [38] TREATMENT OF CHEMOTHERAPY-REFRACTORY METASTATIC UROTHELIAL TUMORS
    LOGOTHETIS, C
    UROLOGIC CLINICS OF NORTH AMERICA, 1992, 19 (04) : 775 - 777
  • [39] 18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy.
    D'Angelo, Sandra P.
    Russell, Jeffery Scott
    Bhatia, Shailender
    Hamid, Omid
    Mehnert, Janice M.
    Terheyden, Patrick
    Shih, Kent C.
    Brownell, Isaac
    Lebbe, Celeste
    Lewis, Karl D.
    Linette, Gerald P.
    Milella, Michele
    Hennessy, Meliessa
    Bajars, Marcis
    Zwiener, Isabella
    Nghiem, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [40] Favorable Response to Treatment with Avelumab in an HIV-Positive Patient with Advanced Merkel Cell Carcinoma Previously Refractory to Chemotherapy
    Al Homsi, Mohammed U.
    Mostafa, Mai
    Fahim, Khaled
    CASE REPORTS IN ONCOLOGY, 2018, 11 (02): : 467 - 475
12345